439 related articles for article (PubMed ID: 21474310)
1. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
[TBL] [Abstract][Full Text] [Related]
2. Parasitology. Drugs to combat tropical protozoan parasites.
Gelb MH; Hol WG
Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
[No Abstract] [Full Text] [Related]
3. In vitro activities of plant extracts from Saudi Arabia against malaria, leishmaniasis, sleeping sickness and Chagas disease.
Abdel-Sattar E; Maes L; Salama MM
Phytother Res; 2010 Sep; 24(9):1322-8. PubMed ID: 20127723
[TBL] [Abstract][Full Text] [Related]
4. 8,8-dialkyldihydroberberines with potent antiprotozoal activity.
Endeshaw M; Zhu X; He S; Pandharkar T; Cason E; Mahasenan KV; Agarwal H; Li C; Munde M; Wilson WD; Bahar M; Doskotch RW; Kinghorn AD; Kaiser M; Brun R; Drew ME; Werbovetz KA
J Nat Prod; 2013 Mar; 76(3):311-5. PubMed ID: 23167812
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
Bakunov SA; Bakunova SM; Wenzler T; Barszcz T; Werbovetz KA; Brun R; Tidwell RR
J Med Chem; 2008 Nov; 51(21):6927-44. PubMed ID: 18841956
[TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis).
Bouchikhi F; Anizon F; Brun R; Moreau P
Bioorg Med Chem Lett; 2011 Nov; 21(21):6319-21. PubMed ID: 21937228
[TBL] [Abstract][Full Text] [Related]
7. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
Werbovetz K
Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
[TBL] [Abstract][Full Text] [Related]
8. A novel isoflavonoid from Millettia puguensis.
Kapingu MC; Mbwambo ZH; Moshi MJ; Magadula JJ; Cos P; Berghe DV; Maes L; Theunis M; Apers S; Pieters L; Vlietinck A
Planta Med; 2006 Nov; 72(14):1341-3. PubMed ID: 17054049
[TBL] [Abstract][Full Text] [Related]
9. In vitro antiprotozoal activities and cytotoxicity of some selected Cameroonian medicinal plants.
Ndjakou Lenta B; Vonthron-Sénécheau C; Fongang Soh R; Tantangmo F; Ngouela S; Kaiser M; Tsamo E; Anton R; Weniger B
J Ethnopharmacol; 2007 Apr; 111(1):8-12. PubMed ID: 17141994
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of antileishmanials neolignan analogues.
Aveniente M; Pinto EF; Santos LS; Rossi-Bergmann B; Barata LE
Bioorg Med Chem; 2007 Dec; 15(23):7337-43. PubMed ID: 17888668
[TBL] [Abstract][Full Text] [Related]
11. The antiprotozoal activity of sixteen asteraceae species native to Sudan and bioactivity-guided isolation of xanthanolides from Xanthium brasilicum.
Nour AM; Khalid SA; Kaiser M; Brun R; Abdallah WE; Schmidt TJ
Planta Med; 2009 Oct; 75(12):1363-8. PubMed ID: 19431098
[TBL] [Abstract][Full Text] [Related]
12. Potent and selective antiplasmodial activity of the cyanobacterial alkaloid nostocarboline and its dimers.
Barbaras D; Kaiser M; Brun R; Gademann K
Bioorg Med Chem Lett; 2008 Aug; 18(15):4413-5. PubMed ID: 18606541
[TBL] [Abstract][Full Text] [Related]
13. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
[TBL] [Abstract][Full Text] [Related]
14. Promising lead compounds for novel antiprotozoals.
Otoguro K; Iwatsuki M; Ishiyama A; Namatame M; Nishihara-Tukashima A; Shibahara S; Kondo S; Yamada H; Omura S
J Antibiot (Tokyo); 2010 Jul; 63(7):381-4. PubMed ID: 20661239
[No Abstract] [Full Text] [Related]
15. Alsinol, an arylamino alcohol derivative active against Plasmodium, Babesia, Trypanosoma, and Leishmania: past and new outcomes.
Arias MH; Quiliano M; Bourgeade-Delmas S; Fabing I; Chantal I; Berthier D; Minet C; Eparvier V; Sorres J; Stien D; Galiano S; Aldana I; Valentin A; Garavito G; Deharo E
Parasitol Res; 2020 Oct; 119(10):3503-3515. PubMed ID: 32772176
[TBL] [Abstract][Full Text] [Related]
16. Antiprotozoal compounds from Psorothamnus polydenius.
Salem MM; Werbovetz KA
J Nat Prod; 2005 Jan; 68(1):108-11. PubMed ID: 15679330
[TBL] [Abstract][Full Text] [Related]
17. Antiparasitic agents: new drugs on the horizon.
Mäser P; Wittlin S; Rottmann M; Wenzler T; Kaiser M; Brun R
Curr Opin Pharmacol; 2012 Oct; 12(5):562-6. PubMed ID: 22652215
[TBL] [Abstract][Full Text] [Related]
18. 1,4-Dihydroxy-2,3-dioxatricyclo[8.4.0.0(4,9)]tetradecane and derivatives with in vitro activity against Plasmodium falciparum, Trypanasoma b brucei, Trypanasoma cruzi, and Leishmaniasis infantum.
Howarth J; Wilson D
Bioorg Med Chem Lett; 2003 Jun; 13(12):2013-5. PubMed ID: 12781185
[TBL] [Abstract][Full Text] [Related]
19. SAR studies on azasterols as potential anti-trypanosomal and anti-leishmanial agents.
Gigante F; Kaiser M; Brun R; Gilbert IH
Bioorg Med Chem; 2009 Aug; 17(16):5950-61. PubMed ID: 19620005
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
